SUBJECTS : Psychopharmacology | Mental Health | Psychiatry | Mental Disorder
Therapeutic Advances in Psychopharmacology: 2023, vol: 13, issue:
- 1)- Antonio Augusto Schmitt Junior, Lucas Primo de Carvalho Alves, Barbara Larissa Padilha, Neusa Sica da Rocha. Serum cytokine variations among inpatients with major depression, bipolar disorder, and schizophrenia healthy controls: a prospective 'true-to-life' study. Therapeutic advances in psychopharmacology. 2023, 13: 20451253221135463
Cited : 3Read More - 2)- David Taylor, Koichiro Watanabe. Tardive dyskinesia: understanding current challenges in diagnosis and treatment. Therapeutic advances in psychopharmacology. 2023, 13: 20451253221144347Cited : 2Read More
- 3)- Christy Huff, A J Reid Finlayson, D E Foster, Peter R Martin. Enduring neurological sequelae of benzodiazepine use: an Internet survey. Therapeutic advances in psychopharmacology. 2023, 13: 20451253221145561Cited : 4Read More
- 4)- Fabrice Jollant, Romain Colle, Thi Mai Loan Nguyen, Emmanuelle Corruble, Alain M Gardier, Martin Walter, Mocrane Abbar, Gerd Wagner. Ketamine and esketamine in suicidal thoughts and behaviors: a systematic review. Therapeutic advances in psychopharmacology. 2023, 13: 20451253231151327Cited : 17Read More
- 5)- Ingrid Lieber, Michael Ott, Robert Lundqvist, Mats Eliasson, Ursula Werneke. Incidence of hyperthyroidism in patients with bipolar or schizoaffective disorder with or without lithium: 21-year follow-up from the LiSIE retrospective cohort study. Therapeutic advances in psychopharmacology. 2023, 13: 20451253231151514Cited : 4Read More
- 6)- Si Bo Liu, Shan Liu, Kai Gao, Guo Zhi Wu, Guo Zu, Jin Jie Liu. Olanzapine for the treatment of ICU delirium: a systematic review and meta-analysis. Therapeutic advances in psychopharmacology. 2023, 13: 20451253231152113Cited : 2Read More
- 7)- Anya Ragnhildstveit, Jeremy Roscoe, Lisa C Bass, Christopher L Averill, Chadi G Abdallah, Lynnette A Averill. The potential of ketamine for posttraumatic stress disorder: a review of clinical evidence. Therapeutic advances in psychopharmacology. 2023, 13: 20451253231154125Cited : 5Read More
- 8)- Alexander T Gallo, Stephen Addis, Vlad Martyn, Hishani Ramanathan, Grace K Wilkerson, Kellie S Bennett, Sean D Hood, Hans Stampfer, Gary K Hulse. The role of flumazenil in generalised anxiety disorder: a pilot naturalistic open-label study with a focus on treatment resistance. Therapeutic advances in psychopharmacology. 2023, 13: 20451253231156400Cited : 0Read More
- 9)- John M Kane, Jose M Rubio. The place of long-acting injectable antipsychotics in the treatment of schizophrenia. Therapeutic advances in psychopharmacology. 2023, 13: 20451253231157219Cited : 0Read More
- 10)- Mishal Qubad, Robert A Bittner. Second to none: rationale, timing, and clinical management of clozapine use in schizophrenia. Therapeutic advances in psychopharmacology. 2023, 13: 20451253231158152Cited : 5Read More
- 11)- Francesco Bartoli, Daniele Cavaleri, Christian Nasti, Dario Palpella, Pierluca Guzzi, Ilaria Riboldi, Cristina Crocamo, Sofia Pappa, Giuseppe Carrà. Long-acting injectable antipsychotics for the treatment of bipolar disorder: evidence from mirror-image studies. Therapeutic advances in psychopharmacology. 2023, 13: 20451253231163682Cited : 9Read More
- 12)- Femin Prasad, Riddhita De, Vittal Korann, Araba F Chintoh, Gary Remington, Bjørn H Ebdrup, Dan Siskind, Filip Krag Knop, Tina Vilsbøll, Anders Fink-Jensen, Margaret K Hahn, Sri Mahavir Agarwal. Semaglutide for the treatment of antipsychotic-associated weight gain in patients not responding to metformin - a case series. Therapeutic advances in psychopharmacology. 2023, 13: 20451253231165169Cited : 8Read More
- 13)- Louisa Gannon, John Reynolds, Martin Mahon, Fiona Gaughran, John Lally. High-dose olanzapine in treatment-resistant schizophrenia: a systematic review. Therapeutic advances in psychopharmacology. 2023, 13: 20451253231168788Cited : 1Read More
- 14)- Vivian W L Tsang, Brendan Tao, Shannon Dames, Zach Walsh, Pam Kryskow. Safety and tolerability of intramuscular and sublingual ketamine for psychiatric treatment in the Roots To Thrive ketamine-assisted therapy program: a retrospective chart review. Therapeutic advances in psychopharmacology. 2023, 13: 20451253231171512Cited : 1Read More
- 15)- Jim van Os, Peter C Groot. Outcomes of hyperbolic tapering of antidepressants. Therapeutic advances in psychopharmacology. 2023, 13: 20451253231171518Cited : 5Read More
- 16)- Ricarda Evens, Marianna Elisa Schmidt, Tomislav Majić, Timo Torsten Schmidt. The psychedelic afterglow phenomenon: a systematic review of subacute effects of classic serotonergic psychedelics. Therapeutic advances in psychopharmacology. 2023, 13: 20451253231172254Cited : 4Read More
- 17)- Hui Juan Chen, Jun Ke, Jie Qiu, Qiang Xu, Yuan Zhong, Guang Ming Lu, Yanglei Wu, Rongfeng Qi, Feng Chen. Altered whole-brain resting-state functional connectivity and brain network topology in typhoon-related post-traumatic stress disorder. Therapeutic advances in psychopharmacology. 2023, 13: 20451253231175302Cited : 1Read More
- 18)- David Healy. The past, present and future of anticholinergic drugs. Therapeutic advances in psychopharmacology. 2023, 13: 20451253231176375Cited : 0Read More
- 19)- Robin Emsley. Antipsychotics and structural brain changes: could treatment adherence explain the discrepant findings? Therapeutic advances in psychopharmacology. 2023, 13: 20451253231195258Cited : 0Read More
- 20)- Delia Bishara. Anticholinergic action is rarely a good thing. Therapeutic advances in psychopharmacology. 2023, 13: 20451253231195264Cited : 0Read More
- 21)- David M Carlson, Brandon C Yarns. Managing medical and psychiatric multimorbidity in older patients. Therapeutic advances in psychopharmacology. 2023, 13: 20451253231195274Cited : 1Read More
- 22)- Morgan Faeder, Elizabeth Hale, Daniel Hedayati, Alex Israel, Darcy Moschenross, Melanie Peterson, Ryan Peterson, Mariel Piechowicz, Jonathan Punzi, Priya Gopalan. Preventing and treating delirium in clinical settings for older adults. Therapeutic advances in psychopharmacology. 2023, 13: 20451253231198462Cited : 0Read More
- 23)- James R O'Neill, David M Taylor, Mark A Horowitz. Implementing gradual, hyperbolic tapering of long-acting injectable antipsychotics by prolonging the inter-dose interval: an modelling study. Therapeutic advances in psychopharmacology. 2023, 13: 20451253231198463Cited : 2Read More
- 24)- Michiel van Elk, Eiko I Fried. History repeating: guidelines to address common problems in psychedelic science. Therapeutic advances in psychopharmacology. 2023, 13: 20451253231198466Cited : 14Read More
- 25)- Caiji Zheng, Haiyan Liu, Weifeng Tu, Lingyun Lin, Haiyun Xu. Hypercoagulable state in patients with schizophrenia: different effects of acute and chronic antipsychotic medications. Therapeutic advances in psychopharmacology. 2023, 13: 20451253231200257Cited : 2Read More
- 26)- Ibrahim Turkoz, Joshua Wong, Benjamin Chee, Uzma Siddiqui, R Karl Knight, Ute Richarz, Christoph U Correll. Comparative effectiveness study of paliperidone palmitate 6-month with a real-world external comparator arm of paliperidone palmitate 1-month or 3-month in patients with schizophrenia. Therapeutic advances in psychopharmacology. 2023, 13: 20451253231200258Cited : 1Read More
- 27)- Na Zhou, Chengchuan Chen, Yubei Liu, Zhaolan Yu, Yanhua Chen. Efficacy of intraoperative subanesthetic dose of ketamine/esketamine in preventing postoperative cognitive dysfunction: a systematic review and meta-analysis. Therapeutic advances in psychopharmacology. 2023, 13: 20451253231200261Cited : 1Read More
- 28)- Farhan Fancy, Sipan Haikazian, Danica E Johnson, David C J Chen-Li, Anastasia Levinta, Muhammad I Husain, Rodrigo B Mansur, Joshua D Rosenblat. Ketamine for bipolar depression: an updated systematic review. Therapeutic advances in psychopharmacology. 2023, 13: 20451253231202723Cited : 1Read More
- 29)- Grimur Høgnason Mohr, Carlo Alberto Barcella, Mia Klinten Grand, Margit Kriegbaum, Volkert Siersma, Margaret K Hahn, Sri Mahavir Agarwal, Catrine Bakkedal, Lone Baandrup, Filip Krag Knop, Christen Lykkegaard Andersen, Bjørn Hylsebeck Ebdrup. Management of dyslipidaemia in individuals with severe mental illness: a population-based study in the Greater Copenhagen Area. Therapeutic advances in psychopharmacology. 2023, 13: 20451253231211574Cited : 0Read More
- 30)- Rashmi Patel, Aimee Brinn, Jessica Irving, Jaya Chaturvedi, Shanmukha Gudiseva, Christoph U Correll, Paolo Fusar-Poli, Philip McGuire. Oral and long-acting injectable antipsychotic discontinuation and relationship to side effects in people with first episode psychosis: a longitudinal analysis of electronic health record data. Therapeutic advances in psychopharmacology. 2023, 13: 20451253231211575Cited : 1Read More
- 31)- Lisanne Koomen, Ilona van de Meent, Floor Elferink, Ingeborg Wilting, Wiepke Cahn. Prevalence and predictors of inappropriate prescribing in outpatients with severe mental illness. Therapeutic advances in psychopharmacology. 2023, 13: 20451253231211576Cited : 0Read More
- 32)- Sarah T Stahl, Joelle Kincman, Jordan F Karp, Marie Anne Gebara. Psychosocial interventions to improve adherence in depressed and anxious older adults prescribed antidepressant pharmacotherapy: a scoping review. Therapeutic advances in psychopharmacology. 2023, 13: 20451253231212322Cited : 0Read More
- 33)- Maytinee Srifuengfung, Bethany R Tellor Pennington, Eric J Lenze. Optimizing treatment for older adults with depression. Therapeutic advances in psychopharmacology. 2023, 13: 20451253231212327Cited : 1Read More
- 34)- Shen He, Yimin Yu, Jingjing Huang, Jiahui Yin, Yajuan Niu, Yazhou Lu, Bin Wu, Maosheng Fang, Xue Wang, Zhiping Tao, Lehua Li, Kan Li, Yan Li, Xiujuan Ding, Yifeng Shen, Huafang Li. A 6-week, phase IIb, randomized, double-blind, placebo-controlled trial of Anyu Peibo capsules for the treatment of major depressive disorder in adults. Therapeutic advances in psychopharmacology. 2023, 13: 20451253231212342Cited : 0Read More
- 35)- Juan Antonio García-Carmona, Alba García-Pérez, Guillermo Isidro García, Luis Alberto Forcen-Muñoz, Santiago Ovejero García, Rocío Sáez Povedano, Ana Luisa González-Galdámez, Laura Mata Iturralde, Fernando Hernández-Sánchez, Mariluz Ramirez Bonilla, Paloma Fuentes-Pérez, Claudia Ovejas-Catalán, Paula Suárez-Pinilla, Francisco Valdivia-Muñoz, Blanca Fernández Abascal, Miguel Omaña Colmenares, Ángela de Lourdes Martín-Pérez, María Pilar Campos-Navarro, Enrique Baca-García, Sergio Benavente-López, . Preliminary data from a 4-year mirror-image and multicentre study of patients initiating paliperidone palmitate 6-monthly long-acting injectable antipsychotic: the Paliperidone 2 per Year study. Therapeutic advances in psychopharmacology. 2023, 13: 20451253231220907Cited : 0Read More
